Financhill
Back

BioCardia 10K Form

Sell
32

BCDA
BioCardia

Last Price:
2.45
Seasonality Move:
10.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BCDA News And Ratings

See the #1 stock for the next 7 days that we like better than BCDA

BCDA Financial Statistics

Sales & Book Value

Annual Sales: $477K
Cash Flow: $-1.32M
Price / Cash Flow: 0
Annual Sales: $-0.92
Price / Book: 0

Profitability

EPS (TTM): -5.38000
Net Income (TTM): $-8.56M
Gross Margin: $1.02M
Return on Equity: 0%
Return on Assets: -228.95%

BioCardia Earnings Forecast

Key BioCardia Financial Ratios

  • The Gross Profit Margin over the past 26 years for BCDA is 100.49%.
  • The Selling, General & Administrative Expenses for BCDA have been equal to 921.38% of Gross Profit Margin.
  • The Research & Development expenses have been 1,619.71% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of BCDA is -2,425.79% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 17 years.

BioCardia Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BCDA
Website: biocardia.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.39
Quick Ratio: 0.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BCDA Technical Analysis vs Fundamental Analysis

Sell
32
BioCardia (BCDA) is a Sell

Is BioCardia a Buy or a Sell?

  • BioCardia stock is rated a Sell
    The current BioCardia [BCDA] share price is $2.43. The Score for BCDA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.